|
1) Hoshino T, Okamoto M, Takei S, et al. Redox-regulated mechanisms in asthma. Antioxid Redox Signal. 2008; 10: 769-83
|
|
|
|
2) Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol. 2010; 72: 495-516
|
|
|
|
|
|
3) Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family？ Immunol Rev. 2008; 226: 248-62. Epub 2009/01/24
|
|
|
|
|
|
4) Rouvier E, Luciani MF, Mattei MG, et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus saimiri gene. J Immunol. 1993; 150: 5445-56
|
|
|
|
|
|
5) Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 2001; 20: 5332-41. Epub 2001/09/28
|
|
|
|
|
|
6) Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995; 3: 811-21. Epub 1995/12/01
|
|
|
|
|
|
7) Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004; 21: 467-76. Epub 2004/10/16
|
|
|
|
|
|
8) Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001; 15: 985-95. Epub 2002/01/05
|
|
|
|
|
|
9) Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med. 2007; 204: 1509-17
|
|
|
|
|
|
10) Ivanov, II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17＋ T helper cells. Cell. 2006; 126: 1121-33. Epub 2006/09/23
|
|
|
|
|
|
11) Hoeve MA, Savage ND, de Boer T, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol. 2006; 36: 661-70. Epub 2006/02/17
|
|
|
|
|
|
12) Vanaudenaerde BM, Verleden SE, Vos R, et al. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am J Respir Crit Care Med. 2011; 183: 977-86. Epub 2010/11/26
|
|
|
|
|
|
13) Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol. 2002; 26: 748-53. Epub 2002/05/30
|
|
|
|
|
|
14) Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996; 183: 2593-603. Epub 1996/ 06/01
|
|
|
|
|
|
15) Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999; 162: 2347-52. Epub 1999/02/11
|
|
|
|
|
|
16) McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008; 181: 4089-97
|
|
|
|
|
|
17) Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008; 14: 275-81. Epub 2008/02/12
|
|
|
|
|
|
18) Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem. 2003; 278: 17036-43
|
|
|
|
|
|
19) McAllister F, Henry A, Kreindler JL, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol. 2005; 175: 404-12. Epub 2005/06/24
|
|
|
|
|
|
20) Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol. 2003; 111: 1293-8
|
|
|
|
|
|
21) Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyper-responsiveness to methacholine. Respir Med. 2003; 97: 726-33
|
|
|
|
|
|
22) Hizawa N, Kawaguchi M, Huang SK, et al. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin Exp Allergy. 2006; 36: 1109-14
|
|
|
|
|
|
23) Kawaguchi M, Takahashi D, Hizawa N, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol. 2006; 117: 795-801
|
|
|
|
|
|
24) Di Stefano A, Caramori G, Gnemmi I, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol. 2009; 157: 316-24. Epub 2009/07/17
|
|
|
|
|